Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six company-sponsored Epidiolex® (cannabidiol) oral solution presentations, including three late-breaking abstracts, will be shared at the upcoming 2022 American Epilepsy Society (AES) annual meeting, which will be held December 2-6, 2022, in Nashville, TN. Read the full article here.
Details
Justin Fields regained consciousness in the back of the ambulance with no recollection of what had happened. All he remembered from that morning in ninth grade was feeling “a little bit off” as he headed to Harrison High School in Kennesaw, Georgia. Read the full article here.
Details
Epilepsy is a neurological disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. On the Mayo Clinic Q&A podcast, Dr. Van Gompel discusses the latest treatment options for epilepsy and what’s on the horizon in research. Watch the full video here.
Details
The location and characteristics of an epilepsy center in the United States could affect the types of presurgical testing given to patients with drug-resistant epilepsy, according to study findings published in Epilepsia. This could have implications on disparities in treatment for these patients. Read the full article here.
Details
Epilepsy is a chronic disorder in which brain cells produce abnormal electrical signals in the brain, causing repeated seizures (via Cleveland Clinic). It’s one of the most common neurological disorders worldwide, affecting about 50 million people, according to the World Health Organization. Read the full article here.
Details
Cannabinoids have been shown to effectively control seizures across the epilepsy spectrum; however, quality control of products remains a challenge, according to a presenter at BRAINWeek 2022. Read the full article here.
Details
In the mammalian brain, the chief inhibitory neurotransmitter is called GABA. The gene SLC6A1 encodes the GABA transporter GAT1, and in Neurobiology of Disease, Felicia Mermer, Sarah Poliquin, Jing-Qiong Kang, MD, PhD, and colleagues report experiments — in silico, in vitro and in mice-o — tying novel variants in SLC6A1 to a childhood syndrome called myoclonic atonic epilepsy (MAE). Read the full article…
Details
Epilepsy is an unpredictable and often misunderstood disease. When the condition isn’t controlled, seizures can happen at any time and disrupt your life, relationships and wellbeing. Neurologists and neurosurgeons at the Nebraska Medicine Comprehensive Epilepsy Center can help you live seizure-free. Find out the latest treatment options for people with epilepsy – including whether the keto diet…
Details
It doesn’t take a soothsayer to see what’s on the horizon for Seer Medical. Thanks to a recently bestowed FDA clearance, the Australian startup is now preparing to begin the U.S. launch of its epilepsy diagnostic monitoring technology, it announced Monday. Read the full article here.
Details